Journal of Cancer Therapy

Vol.7 No.4(2016), Paper ID 65797, 12 pages

DOI:10.4236/jct.2016.74030

 

Characterization of Genomic Events Other than Ph and Evaluation of Prognostic Influence on Imatinib in Chronic Myeloid Leukemia (CML): A Study on 1449 Patients from India

 

P. S. Kadam Amare, H. Jain, S. Kabre, D. Walke, H. Menon, M. Sengar, N. Khatri, B. Bagal, U. Dangi, H. Jain, P. G. Subramanian, S. Gujral

 

Cancer Cytogenetics Department, Tata Memorial Hospital, Mumbai, India
Cancer Cytogenetics Department, Tata Memorial Hospital, Mumbai, India
Cancer Cytogenetics Department, Tata Memorial Hospital, Mumbai, India
Cancer Cytogenetics Department, Tata Memorial Hospital, Mumbai, India
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
Hematopathology Laboratory, Department of Pathology, Tata Memorial Hospital, Mumbai, India
Hematopathology Laboratory, Department of Pathology, Tata Memorial Hospital, Mumbai, India

 

Copyright © 2016 P. S. Kadam Amare, H. Jain, S. Kabre, D. Walke, H. Menon, M. Sengar, N. Khatri, B. Bagal, U. Dangi, H. Jain, P. G. Subramanian, S. Gujral et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Amare, P. , Jain, H. , Kabre, S. , Walke, D. , Menon, H. , Sengar, M. , Khatri, N. , Bagal, B. , Dangi, U. , Jain, H. , Subramanian, P. and Gujral, S. (2016) Characterization of Genomic Events Other than Ph and Evaluation of Prognostic Influence on Imatinib in Chronic Myeloid Leukemia (CML): A Study on 1449 Patients from India. Journal of Cancer Therapy, 7, 285-296. doi: 10.4236/jct.2016.74030.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.